financetom
Business
financetom
/
Business
/
Onestream Insider Sold Shares Worth $847,827, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Onestream Insider Sold Shares Worth $847,827, According to a Recent SEC Filing
Jun 24, 2025 1:49 PM

04:33 PM EDT, 06/24/2025 (MT Newswires) -- John Kinzer, Director, on June 20, 2025, sold 30,000 shares in Onestream ( OS ) for $847,827. Following the Form 4 filing with the SEC, Kinzer has control over a total of 7,130 Class A common shares of the company, with 7,130 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1889956/000141588925018087/xslF345X05/form4-06242025_080604.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Integral Metals Announces Flow-Through Private Placement to Raise up to C$1 Million
Integral Metals Announces Flow-Through Private Placement to Raise up to C$1 Million
Oct 17, 2025
09:59 AM EDT, 10/17/2025 (MT Newswires) -- Integral Metals ( ITGLF ) Friday said it plans to complete a non-brokered flow-through private placement of units priced at $0.95 each for gross proceeds of up to C$1 million. Each unit will be made up of one flow-through common share of the company and one non-flow-through common share purchase warrant of the...
Form 8.3 - UTG LN
Form 8.3 - UTG LN
Oct 17, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming...
Vertex Pharma Says FDA Grants Rolling Review of Povetacicept Application for IgA Nephropathy
Vertex Pharma Says FDA Grants Rolling Review of Povetacicept Application for IgA Nephropathy
Oct 17, 2025
09:59 AM EDT, 10/17/2025 (MT Newswires) -- Vertex Pharmaceuticals ( VRTX ) said Friday that the US Food and Drug Administration recently granted a rolling review of a biologics license application on povetacicept for the treatment of IgA nephropathy. The company said it expects to submit povetacicept's first module to the FDA before the end of the year and complete...
Form 8.3 - ESP LN
Form 8.3 - ESP LN
Oct 17, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming...
Copyright 2023-2026 - www.financetom.com All Rights Reserved